Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
Sanofi will acquire Ablynx and get its hands on the biotech's exciting Nanobody technology just…
Ablynx CEO Edwin Moses discusses the technology and strategy that has led its company to…
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a…
Ablynx has triumphed where others have fallen by receiving positive Phase III results for the…
Argenx' partner Staten Biotechnology has published results that present a drug licensed from the Belgian…
Ablynx and Sanofi have entered a research collaboration and exclusive licensing agreement for up to…
Ablynx is receiving its first milestone payment from a deal with Merck for the development…
Merck has signed a new agreement with Avillion for its nanobody against psoriasis. Avillion will…
Ablynx has treated its first patient in a new trial targeting RSV infections, the main…
Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants…